|
1
|
Muyayalo KP, Li ZH, Mor G and Liao AH:
Modulatory effect of intravenous immunoglobulin on Th17/Treg cell
balance in women with unexplained recurrent spontaneous abortion.
Am J Reprod Immunol. 80:e130182018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen X, Yin B, Lian RC, Zhang T, Zhang HZ,
Diao LH, Li YY, Huang CY, Liang DS and Zeng Y: Modulatory effects
of vitamin D on peripheral cellular immunity in patients with
recurrent miscarriage. Am J Reprod Immunol. 76:432–438. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang X, Yang E, Wang WJ, He Q, Jubiz G,
Katukurundage D, Dambaeva S, Beaman K and Kwak-Kim J: Decreased
HLA-C1 alleles in couples of KIR2DL2 positive women with recurrent
pregnancy loss. J Reprod Immunol. 142:1031862020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yan X, Wang L, Yan C, Zhang X, Hui L,
Sheng Q, Xue M and Yu X: Decreased expression of the vitamin D
receptor in women with recurrent pregnancy loss. Arch Biochem
Biophys. 606:128–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jeve YB and Davies W: Evidence-based
management of recurrent miscarriages. J Hum Reprod Sci. 7:159–169.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rand JH, Wu XX, Andree HA, Lockwood CJ,
Guller S, Scher J and Harpel PC: Pregnancy loss in the
antiphospholipid-antibody syndrome-a possible thrombogenic
mechanism. N Engl J Med. 337:154–160. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mecacci F, Parretti E, Cioni R, Lucchetti
R, Magrini A, La Torre P, Mignosa M, Acanfora L and Mello G:
Thyroid autoimmunity and its association with non-organ-specific
antibodies and subclinical alterations of thyroid function in women
with a history of pregnancy loss or preeclampsia. J Reprod Immunol.
46:39–50. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cavalcante MB, Cavalcante C, Sarno M, da
Silva ACB and Barini R: Antinuclear antibodies and recurrent
miscarriage: Systematic review and meta-analysis. Am J Reprod
Immunol. 83:e132152020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sakthiswary R, Rajalingam S, Norazman MR
and Hussein H: Antinuclear antibodies predict a higher number of
pregnancy loss in unexplained recurrent pregnancy loss. Clin Ter.
166:e98–e101. 2015.PubMed/NCBI
|
|
10
|
Kwak JY, Beaman KD, Gilman-Sachs A, Ruiz
JE, Schewitz D and Beer AE: Up-regulated expression of
CD56+, CD56+/CD16+, and
CD19+ cells in peripheral blood lymphocytes in pregnant
women with recurrent pregnancy losses. Am J Reprod Immunol.
34:93–99. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aoki K, Kajiura S, Matsumoto Y, Ogasawara
M, Okada S, Yagami Y and Gleicher N: Preconceptional
natural-killer-cell activity as a predictor of miscarriage. Lancet.
345:1340–1342. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yougbaré I, Tai WS, Zdravic D, Oswald BE,
Lang S, Zhu G, Leong-Poi H, Qu D, Yu L, Dunk C, et al: Activated NK
cells cause placental dysfunction and miscarriages in fetal
alloimmune thrombocytopenia. Nat Commun. 8:2242017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sasaki Y, Sakai M, Miyazaki S, Higuma S,
Shiozaki A and Saito S: Decidual and peripheral blood
CD4+CD25+ regulatory T cells in early
pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod.
10:347–353. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stricker RB, Steinleitner A and Winger EE:
Intravenous immunoglobulin (IVIG) therapy for immunologic abortion.
Clin Appl Immunol Rev. 2:187–199. 2002. View Article : Google Scholar
|
|
15
|
Bansal AS, Bajardeen B and Thum MY: The
basis and value of currently used immunomodulatory therapies in
recurrent miscarriage. J Reprod Immunol. 93:41–51. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Novac N, Baus D, Dostert A and Heinzel T:
Competition between glucocorticoid receptor and NFkappaB for
control of the human FasL promoter. FASEB J. 20:1074–1081. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pasquier E, de Saint-Martin L, Marhic G,
Chauleur C, Bohec C, Bretelle F, Lejeune-Saada V, Hannigsberg J,
Plu-Bureau G, Cogulet V, et al: Hydroxychloroquine for prevention
of recurrent miscarriage: Study protocol for a multicentre
randomised placebo-controlled trial BBQ study. BMJ Open.
9:e0256492019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee SK, Kim JY, Han AR, Hur SE, Kim CJ,
Kim TH, Cho BR, Han JW, Han SG, Na BJ and Kwak-Kim J: Intravenous
immunoglobulin G improves pregnancy outcome in women with recurrent
pregnancy losses with cellular immune abnormalities. Am J Reprod
Immunol. 75:59–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim DJ, Lee SK, Kim JY, Na BJ, Hur SE, Lee
M and Kwak-Kim J: Intravenous immunoglobulin G modulates peripheral
blood Th17 and Foxp3(+) regulatory T cells in pregnant women with
recurrent pregnancy loss. Am J Reprod Immunol. 71:441–450. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kwak JY, Quilty EA, Gilman-Sachs A, Beaman
KD and Beer AE: Intravenous immunoglobulin infusion therapy in
women with recurrent spontaneous abortions of immune etiologies. J
Reprod Immunol. 28:175–188. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han AR, Ahn H, Vu P, Park JC, Gilman-Sachs
A, Beaman K and Kwak-Kim J: Obstetrical outcome of
anti-inflammatory and anticoagulation therapy in women with
recurrent pregnancy loss or unexplained infertility. Am J Reprod
Immunol. 68:418–427. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schwab I and Nimmerjahn F: Intravenous
immunoglobulin therapy: How does IgG modulate the immune system?
Nat Rev Immunol. 13:176–189. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hutton B, Sharma R, Fergusson D, Tinmouth
A, Hebert P, Jamieson J and Walker M: Use of intravenous
immunoglobulin for treatment of recurrent miscarriage: A systematic
review. BJOG. 114:134–142. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Panda DK, Miao D, Tremblay ML, Sirois J,
Farookhi R, Hendy GN and Goltzman D: Targeted ablation of the
25-hydroxyvitamin D 1alpha-hydroxylase enzyme: Evidence for
skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci
USA. 98:7498–7503. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brannon PM: Vitamin D and adverse
pregnancy outcomes: Beyond bone health and growth. Proc Nutr Soc.
71:205–212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mora JR, Iwata M and von Andrian UH:
Vitamin effects on the immune system: Vitamins A and D take centre
stage. Nat Rev Immunol. 8:685–698. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ota K, Dambaeva S, Kim MW, Han AR, Fukui
A, Gilman-Sachs A, Beaman K and Kwak-Kim J: 1,25-dihydroxy-vitamin
D3 regulates NK-cell cytotoxicity, cytokine secretion, and
degranulation in women with recurrent pregnancy losses. Eur J
Immunol. 45:3188–3199. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mulligan ML, Felton SK, Riek AE and
Bernal-Mizrachi C: Implications of vitamin D deficiency in
pregnancy and lactation. Am J Obstet Gynecol. 202:429.e1–e9. 2010.
View Article : Google Scholar
|
|
29
|
Ota K, Dambaeva S, Han AR, Beaman K,
Gilman-Sachs A and Kwak-Kim J: Vitamin D deficiency may be a risk
factor for recurrent pregnancy losses by increasing cellular
immunity and autoimmunity. Hum Reprod. 29:208–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee SK, Na BJ, Kim JY, Hur SE, Lee M,
Gilman-Sachs A and Kwak-Kim J: Determination of clinical cellular
immune markers in women with recurrent pregnancy loss. Am J Reprod
Immunol. 70:398–411. 2013.PubMed/NCBI
|
|
31
|
Fukui A, Kwak-Kim J, Ntrivalas E,
Gilman-Sachs A, Lee SK and Beaman K: Intracellular cytokine
expression of peripheral blood natural killer cell subsets in women
with recurrent spontaneous abortions and implantation failures.
Fertil Steril. 89:157–165. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ford HB and Schust DJ: Recurrent pregnancy
loss: Etiology, diagnosis, and therapy. Rev Obstet Gynecol.
2:76–83. 2009.PubMed/NCBI
|
|
33
|
Tavakoli M, Jeddi-Tehrani M,
Salek-Moghaddam A, Rajaei S, Mohammadzadeh A, Sheikhhasani S,
Kazemi-Sefat GE and Zarnani AH: Effects of 1,25(OH)2 vitamin D3 on
cytokine production by endometrial cells of women with recurrent
spontaneous abortion. Fertil Steril. 96:751–757. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lagana AS, Vitale SG, Ban Frangez H,
Vrtacnik-Bokal E and D'Anna R: Vitamin D in human reproduction: The
more, the better? An evidence-based critical appraisal. Eur Rev Med
Pharmacol Sci. 21:4243–4251. 2017.PubMed/NCBI
|
|
35
|
Chighizola CB, de Jesus GR and Branch DW:
The hidden world of anti-phospholipid antibodies and female
infertility: A literature appraisal. Autoimmun Rev. 15:493–500.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cyprian F, Lefkou E, Varoudi K and Girardi
G: Immunomodulatory effects of Vitamin D in pregnancy and beyond.
Front Immunol. 10:27392019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Carp HJ and Shoenfeld Y: Anti-phospholipid
antibodies and infertility. Clin Rev Allergy Immunol. 32:159–161.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Redecha P, Franzke CW, Ruf W, Mackman N
and Girardi G: Neutrophil activation by the tissue factor/Factor
VIIa/PAR2 axis mediates fetal death in a mouse model of
antiphospholipid syndrome. J Clin Invest. 118:3453–3461.
2008.PubMed/NCBI
|
|
39
|
Tobaldini LQ, Arantes FT, Saraiva SDS,
Mazetto BM, Colella MP, de Paula EV, Annichino-Bizzachi J and Orsi
FA: Circulating levels of tissue factor and the risk of thrombosis
associated with antiphospholipid syndrome. Thromb Res. 171:114–120.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tedesco F, Borghi MO, Gerosa M, Chighizola
CB, Macor P, Lonati PA, Gulino A, Belmonte B and Meroni PL:
Pathogenic role of complement in antiphospholipid syndrome and
therapeutic implications. Front Immunol. 9:13882018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Oku K, Atsumi T, Bohgaki M, Amengual O,
Kataoka H, Horita T, Yasuda S and Koike T: Complement activation in
patients with primary antiphospholipid syndrome. Ann Rheum Dis.
68:1030–1035. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Breen KA, Seed P, Parmar K, Moore GW,
Stuart-Smith SE and Hunt BJ: Complement activation in patients with
isolated antiphospholipid antibodies or primary antiphospholipid
syndrome. Thromb Haemost. 107:423–429. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
De Carolis S, Botta A, Santucci S, Salvi
S, Moresi S, Di Pasquo E, Del Sordo G and Martino C: Complementemia
and obstetric outcome in pregnancy with antiphospholipid syndrome.
Lupus. 21:776–778. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Reggia R, Ziglioli T, Andreoli L, Bellisai
F, Iuliano A, Gerosa M, Ramoni V, Tani C, Brucato A, Galeazzi M, et
al: Primary anti-phospholipid syndrome: Any role for serum
complement levels in predicting pregnancy complications?
Rheumatology (Oxford). 51:2186–2190. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Girardi G, Berman J, Redecha P, Spruce L,
Thurman JM, Kraus D, Hollmann TJ, Casali P, Caroll MC, Wetsel RA,
et al: Complement C5a receptors and neutrophils mediate fetal
injury in the antiphospholipid syndrome. J Clin Invest.
112:1644–1654. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Redecha P, Tilley R, Tencati M, Salmon JE,
Kirchhofer D, Mackman N and Girardi G: Tissue factor: A link
between C5a and neutrophil activation in antiphospholipid antibody
induced fetal injury. Blood. 110:2423–2431. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Izban MG, Nowicki BJ and Nowicki S:
1,25-Dihydroxyvitamin D3 promotes a sustained LPS-induced
NF-κB-dependent expression of CD55 in human monocytic THP-1 cells.
PLoS One. 7:e493182012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Agmon-Levin N, Blank M, Zandman-Goddard G,
Orbach H, Meroni PL, Tincani A, Doria A, Cervera R, Miesbach W,
Stojanovich L, et al: Vitamin D: An instrumental factor in the
anti-phospholipid syndrome by inhibition of tissue factor
expression. Ann Rheum Dis. 70:145–150. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
van den Hoogen LL, van Roon JA, Radstake
TR, Fritsch-Stork RD and Derksen RH: Delineating the deranged
immune system in the antiphospholipid syndrome. Autoimmun Rev.
15:50–60. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Martinez-Moreno JM, Herencia C, Montes de
Oca A, Muñoz-Castañeda JR, Rodríguez-Ortiz ME, Díaz-Tocados JM,
Peralbo-Santaella E, Camargo A, Canalejo A, Rodriguez M, et al:
Vitamin D modulates tissue factor and protease-activated receptor 2
expression in vascular smooth muscle cells. FASEB J. 30:1367–1376.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Santos TDS, Ieque AL, de Carvalho HC, Sell
AM, Lonardoni MVC, Demarchi IG, de Lima Neto QA and Teixeira JJV:
Antiphospholipid syndrome and recurrent miscarriage: A systematic
review and meta-analysis. J Reprod Immunol. 123:78–87. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Matalon ST, Blank M, Ornoy A and Shoenfeld
Y: The association between anti-thyroid antibodies and pregnancy
loss. Am J Reprod Immunol. 45:72–77. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Poppe K, Velkeniers B and Glinoer D:
Thyroid disease and female reproduction. Clin Endocrinol.
66:309–321. 2007. View Article : Google Scholar
|
|
54
|
Kivity S, Agmon-Levin N, Zisappl M,
Shapira Y, Nagy EV, Dankó K, Szekanecz Z, Langevitz P and Shoenfeld
Y: Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol.
8:243–247. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
D'Aurizio F, Villalta D, Metus P, Doretto
P and Tozzoli R: Is vitamin D a player or not in the
pathophysiology of autoimmune thyroid diseases? Autoimmun Rev.
14:363–369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Shin DY, Kim KJ, Kim D, Hwang S and Lee
EJ: Low serum vitamin D is associated with anti-thyroid peroxidase
antibody in autoimmune thyroiditis. Yonsei Med J. 55:476–481. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Bhattacharyya R, Mukherjee K, Das A,
Biswas MR, Basunia SR and Mukherjee A: Anti-thyroid peroxidase
antibody positivity during early pregnancy is associated with
pregnancy complications and maternal morbidity in later life. J Nat
Sci Biol Med. 6:402–405. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ozkan S, Jindal S, Greenseid K, Shu J,
Zeitlian G, Hickmon C and Pal L: Replete vitamin D stores predict
reproductive success following in vitro fertilization. Fertil
Steril. 94:1314–1319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Daftary GS and Taylor HS: Endocrine
regulation of HOX genes. Endocrine Rev. 27:331–355. 2006.
View Article : Google Scholar
|
|
60
|
Cippitelli M and Santoni A: Vitamin D3: A
transcriptional modulator of the interferon-gamma gene. Eur J
Immunol. 28:3017–3030. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Takeuchi A, Reddy GS, Kobayashi T, Okano
T, Park J and Sharma S: Nuclear factor of activated T cells (NFAT)
as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated
effects. J Immunol. 160:209–218. 1998.PubMed/NCBI
|
|
62
|
van Etten E and Mathieu C:
Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J
Steroid Biochem Mol Biol. 97:93–101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Piccinni MP, Scaletti C, Maggi E and
Romagnani S: Role of hormone-controlled Th1- and Th2-type cytokines
in successful pregnancy. J Neuroimmunol. 109:30–33. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Adams JS and Hewison M: Unexpected actions
of vitamin D: New perspectives on the regulation of innate and
adaptive immunity. Nat Clin Pract Endocrinol Metab. 4:80–90. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Boonstra A, Barrat FJ, Crain C, Heath VL,
Savelkoul HF and O'Garra A: 1alpha,25-Dihydroxyvitamin d3 has a
direct effect on naive CD4(+) T cells to enhance the development of
Th2 cells. J Immunol. 167:4974–4980. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Overbergh L, Decallonne B, Waer M,
Rutgeerts O, Valckx D, Casteels KM, Laureys J, Bouillon R and
Mathieu C: 1alpha,25-dihydroxyvitamin D3 induces an
autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice
immunized with GAD65 (p524-543). Diabetes. 49:1301–1307. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Gonçalves DR, Braga A, Braga J and Marinho
A: Recurrent pregnancy loss and vitamin D: A review of the
literature. Am J Reprod Immunol. 80:e130222018. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Peterson CA and Heffernan ME: Serum tumor
necrosis factor-alpha concentrations are negatively correlated with
serum 25(OH)D concentrations in healthy women. J Inflamm (Lond).
5:102008. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Abdollahi E, Saghafi N, Rezaee SA, Rastin
M, Jarahi L, Clifton V and Rafatpanah H: Evaluation of 1,25(OH)2D3
Effects on FOXP3, ROR-γt, GITR, and CTLA-4 Gene expression in the
PBMCs of Vitamin D-Deficient Women with unexplained recurrent
pregnancy loss (URPL). Iran Biomed J. 24:295–305. 2020.PubMed/NCBI
|
|
70
|
Holick MF, Binkley NC, Bischoff-Ferrari
HA, Gordon CM, Hanley DA, Heaney RP, Murad MH and Weaver CM;
Endocrine Society, : Evaluation, treatment, and prevention of
vitamin D deficiency: An Endocrine Society clinical practice
guideline. J Clin Endocrinol Metab. 96:1911–1930. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Jeffery LE, Burke F, Mura M, Zheng Y,
Qureshi OS, Hewison M, Walker LS, Lammas DA, Raza K and Sansom DM:
1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell
production of inflammatory cytokines and promote development of
regulatory T cells expressing CTLA-4 and FoxP3. J Immunol.
183:5458–5467. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Ibrahim ZM, madany EH, Abdel Aal RM and El
Biely MM: Role of 1,25-dihydroxyvitamin D (vitamin D3) as
immunomodulator in recurrent missed miscarriage. Middle East
Fertility Soc J. 18:171–176. 2013. View Article : Google Scholar
|
|
73
|
Figueiredo AS and Schumacher A: The T
helper type 17/regulatory T cell paradigm in pregnancy. Immunology.
148:13–21. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Vijayendra Chary A, Hemalatha R,
Seshacharyulu M, Vasudeva Murali M, Jayaprakash D and Dinesh Kumar
B: Vitamin D deficiency in pregnant women impairs regulatory T cell
function. J Steroid Biochem Mol Biol. 147:48–55. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Abdollahi E, Rezaee R, Saghafi N, Rastin
M, Clifton V, Sahebkar A and Rafatpanah H: Evaluation of the
effects of 1,25 vitamin D3 on regulatory T cells and T helper 17
cells in Vitamin D-deficient women with unexplained recurrent
pregnancy loss. Curr Mol Pharmacol. 13:306–317. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Ji J, Zhai H, Zhou H, Song S, Mor G and
Liao A: The role and mechanism of vitamin D-mediated regulation of
Treg/Th17 balance in recurrent pregnancy loss. Am J Reprod Immunol.
81:e131122019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Rafiee M, Gharagozloo M, Ghahiri A,
Mehrabian F, Maracy MR, Kouhpayeh S, Pieper IL and Rezaei A:
Altered Th17/Treg ratio in recurrent miscarriage after treatment
with paternal lymphocytes and Vitamin D3: A Double-blind
placebo-controlled study. Iran J Immunol. 12:252–262.
2015.PubMed/NCBI
|
|
78
|
Li N, Wu HM, Hang F, Zhang YS and Li MJ:
Women with recurrent spontaneous abortion have decreased 25(OH)
vitamin D and VDR at the fetal-maternal interface. Braz J Med Biol
Res. 50:e65272017. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Samimi M, Foroozanfard F, Amini F and
Sehat M: Effect of Vitamin D supplementation on unexplained
recurrent spontaneous abortion: A double-blind randomized
controlled trial. Global J Health Sci. 9:95–102. 2017. View Article : Google Scholar
|
|
80
|
Yang X, Gilman-Sachs A and Kwak-Kim J:
Ovarian and endometrial immunity during the ovarian cycle. J Reprod
Immunol. 133:7–14. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Scarpellini F and Sbracia M: Use of
granulocyte colony-stimulating factor for the treatment of
unexplained recurrent miscarriage: A randomised controlled trial.
Hum Reprod. 24:2703–2708. 2009. View Article : Google Scholar : PubMed/NCBI
|
